ReviewVerification | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

[PCI-5-7-2026] Integrated Solutions for Ultra-High Potent OSD Products
Thursday, May 07, 2026
As pipelines push into ultra-high potency, conventional HPAPI capability is no longer enough. PCI Pharma Services supports oral solid dose manufacturing at validated OEB 5–6 levels, with ... read more
[Primary: Abbvie 5-14-2026]Avoiding Recalls: How to Ensure Sterility in Ophthalmic Products
Wednesday, May 06, 2026
In the wake of several high-profile eye drop recalls, we look at the challenges of achieving sterility in ophthalmic products, the consequences of failing to do so, and how AbbVie Contract ... read more
In-Line, In Real-Time: Advancing Live-Cell Metabolic Monitoring Across the Drug Development Workflow
Tuesday, May 05, 2026
This eBook showcases how live cell monitoring and analysis are advancing metabolic research, immunology, drug development, and more. read more
CPHI Americas
Tuesday, May 05, 2026
CPHI Americas 2026 moves beyond the traditional trade show format to create a premium, content-first experience specifically centered around the contract development and manufacturing ecosystem. ... read more
Parexel Acquires Vitrana to Expand AI-Enabled Patient Safety and Pharmacovigilance Technology
Thursday, April 30, 2026
Parexel announced the acquisition of Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform that supports patient safety and drug safety operations. read more
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
Thursday, April 30, 2026
Achieve Life Sciences announced significant operational progress including the transfer of cytisinicline manufacturing to Adare Pharma Solutions. Achieve has now completed the analytical method ... read more
Frontier Scientific Solutions Appoints Chief Commercial Officer
Thursday, April 30, 2026
Frontier Scientific Solutions announced the appointment of Michelle D’Angelo as Chief Commercial Officer (CCO). read more
BioDuro and CTI Biotechnology Partner to Accelerate Preclinical Drug Development
Wednesday, April 29, 2026
BioDuro announced a strategic partnership with CTI Biotechnology to leverage the complementary strengths of both companies across critical stages of preclinical R&D to establish an integrated platform... read more
LTS Adds Ophthalmic Drug Delivery Solutions
Wednesday, April 29, 2026
LTS LOHMANN Therapie-Systeme AG announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United ... read more
Mikart Opens New Headquarters
Tuesday, April 28, 2026
Mikart announced the opening of its new headquarters in Northwest Atlanta. The new executive headquarters represents a milestone in the company's growth and expansion. read more
Paradigm Health to Collaborate with FDA to Transform Regulatory Review of Clinical Trial Data
Tuesday, April 28, 2026
Paradigm Health announced the launch of a research collaboration with the FDA focused on advancing a new model to accelerate clinical trial execution and regulatory review. read more
PharmaLogic Opens PET Radiopharmaceutical Manufacturing Facility in Atlanta, GA
Tuesday, April 28, 2026
PharmaLogic announced the opening of its new PET radiopharmaceutical manufacturing facility in Atlanta, Georgia. read more
Andelyn Biosciences and ENCell Parner to Expand Global Reach of Gene Therapy Manufacturing
Monday, April 27, 2026
Andelyn Biosciences and ENCell announced the signing of a Collaboration Agreement to establish a strategic manufacturing bridge between the United States and Asia-Pacific (APAC) regions to accelerate ... read more
Mikart and Benuvia Partner to Deliver Controlled Substance Development and Finished Drug Product Manufacturing Solutions
Monday, April 27, 2026
Mikart and Benuvia Operations announced a strategic co-marketing partnership to provide fully integrated, end-to-end solutions spanning drug substance (API) development through finished drug product ... read more
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR T Program
Monday, April 27, 2026
Minaris, a CGT CDMO and multimodality biosafety testing provider and Chimeric Therapeutics, an Australian cell therapy company, announced a 100% batch manufacturing and release success rate in ... read more

Thank You

Thank you for submitting your review!

Product Reviews

[PCI-5-7-2026] Integrated Solutions for Ultra-High Potent OSD Products

[Primary: Abbvie 5-14-2026]Avoiding Recalls: How to Ensure Sterility in Ophthalmic Products

In-Line, In Real-Time: Advancing Live-Cell Metabolic Monitoring Across the Drug Development Workflow

CPHI Americas

Parexel Acquires Vitrana to Expand AI-Enabled Patient Safety and Pharmacovigilance Technology

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Frontier Scientific Solutions Appoints Chief Commercial Officer

BioDuro and CTI Biotechnology Partner to Accelerate Preclinical Drug Development

LTS Adds Ophthalmic Drug Delivery Solutions

Mikart Opens New Headquarters

Paradigm Health to Collaborate with FDA to Transform Regulatory Review of Clinical Trial Data

PharmaLogic Opens PET Radiopharmaceutical Manufacturing Facility in Atlanta, GA

Andelyn Biosciences and ENCell Parner to Expand Global Reach of Gene Therapy Manufacturing

Mikart and Benuvia Partner to Deliver Controlled Substance Development and Finished Drug Product Manufacturing Solutions

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR T Program

Current Issue

Jan/Feb/Mar 2026

2026 Company Focus & Industry Reference Guide

2026 Company Focus & Industry Reference Guide

Subscriptions

Connect with Us

Sign Up for Our Newsletter